摘要
肺巨噬细胞通过特异性和非特异性机制,在先天免疫和免疫反应中发挥作用,即吞噬作用,并且能通过主要组织相容性复合体、T细胞活化与炎性因子的释放而对抗原加工与提呈产生重要影响。尽管他们在正常状态下对损伤有保护作用,但它们能引起多种肺疾病,因为它们可以通过聚集其他炎症细胞形成肺泡空间、释放炎症细胞因子或刺激胶原沉积的来介导疾病过程。肺巨噬细胞是治疗肺病的极佳靶点。随着纳米技术的发展,针对这些细胞的靶向药物的载体已经被科学家所设计。常用的方法之一是使对肺巨噬细胞表面受体具有亲和力的配体附着在纳米载体上。本综重点讲述了肺巨噬细胞在宿主防御中的重要性、其对不同肺疾病的影响,以及肺泡巨噬细胞的靶向性的不同措施。
关键词: 巨噬细胞,给药系统,配体,巨噬细胞受体,甘露糖受体,靶向。
图形摘要
Current Drug Targets
Title:Targeted Drug Delivery Systems for Lung Macrophages
Volume: 16 Issue: 14
Author(s): Ana Costa, Bruno Sarmento and Vítor Seabra
Affiliation:
关键词: 巨噬细胞,给药系统,配体,巨噬细胞受体,甘露糖受体,靶向。
摘要: Lung macrophages present an effective role in innate and immune response through specific and non-specific mechanisms, namely phagocytosis, antigen processing and presentation through major histocompatibility complex, activation of T cells and inflammatory cytokines release. Despite their protective role against injury in normal condition, they can cause several lung conditions, since they can mediate several processes, through recruitment of other inflammatory cells for alveolar space, release of proinflammatory cytokines or stimulation of collagen deposition. Lung macrophages constitute a good therapeutic target. With the development of nanotechnology, new carriers have been designed to target drugs towards these cells. One of the commonly used approaches is the attachment of ligands with affinity to receptors presented at lung macrophage surface, to the nanocarriers. This review will focus on the importance of lung macrophages in host-defense, their influence on different pulmonary diseases and different strategies for alveolar macrophage targeting.
Export Options
About this article
Cite this article as:
Ana Costa, Bruno Sarmento and Vítor Seabra , Targeted Drug Delivery Systems for Lung Macrophages, Current Drug Targets 2015; 16 (14) . https://dx.doi.org/10.2174/1389450115666141114152713
DOI https://dx.doi.org/10.2174/1389450115666141114152713 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Screening Novel SAHA Derivatives as Anti-lung Carcinoma Agents: Synthesis, Biological Evaluation, Docking Studies and Further Mechanism Research between Apoptosis and Autophagyetween Apoptosis and Autophagy
Anti-Cancer Agents in Medicinal Chemistry Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
Current Drug Delivery Role of Nitric Oxide in the Modulation of Angiogenesis
Current Pharmaceutical Design Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy
Current Gene Therapy Chemoprevention of Skin Carcinomas in High-Risk Transplant Recipients
Current Medicinal Chemistry Electrical Impedance Scanning - A New Diagnostic Tool in Cancer Detection: Current Status and Recent Developments
Current Medical Imaging Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins
Anti-Cancer Agents in Medicinal Chemistry Expression of Estrogen-Regulated Genes During Development in the Mouse Uterus Exposed to Diethylstilbestrol Neonatally
Current Pharmaceutical Design Monoclonal Antibodies in Solid Tumours
Current Clinical Pharmacology The Functions of F-box Proteins in Regulating the Epithelial to Mesenchymal Transition
Current Pharmaceutical Design STAT3 as a Therapeutic Target for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges
Current Radiopharmaceuticals Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived Compounds
Current Pharmaceutical Design Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters Roles of Laminin-332 and α6β4 Integrin in Tumor Progression
Mini-Reviews in Medicinal Chemistry Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3<sup>-/-</sup> Mouse Fetuses
MicroRNA Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Current Cancer Drug Targets